{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:57:53Z","timestamp":1787061473430,"version":"build-2736575974"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Severe COVID-19 is associated with reduced absolute lymphocyte counts, suggesting that lymphocyte subsets may serve as predictors of clinical outcomes in affected patients. Early identification of patients at risk for severe disease is crucial for optimizing care, accurately informing patients and their families, guiding therapeutic interventions, and improving patient flow in the ED. Given that immunosuppressive drugs significantly impact lymphocyte profiles, we aimed to determine the association between prior use of immunosuppressive drugs, lymphocyte subsets, and COVID-19 severity in our population with a high prevalence of immunosuppression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In 2021, suspected COVID-19 patients were included in the ED. Lymphocyte subsets were determined in peripheral blood within 24 hours after presentation and comparative analyses was performed between SARS-CoV-2 negative and positive patients, mild versus severe disease and patients with and without prior immunosuppressive drug use. Mild cases were patients discharged home or admitted to a general ward, severe cases were patients with COVID-19-related mortality or necessitating ICU admission. Logistic regression analysis was performed to assess the association between lymphocyte subsets and COVID-19 severity, and between prior immunosuppressive drug use and COVID-19 severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-five SARS-CoV-2 negative and 77 SARS-CoV-2 positive patients were included, whereof 57 (74%) had mild and 20 (26%) severe COVID-19. No significant differences were observed in the absolute counts of CD3+, CD4+, and CD8+ T-lymphocytes, B-lymphocytes, and NK-cells between SARS-CoV-2 negative and positive patients or between mild and severe cases. The 36 patients with prior use of immunosuppressive drugs had significantly lower CD4+ T-lymphocytes (p&amp;lt;0.01). Prior use of immunosuppressive drugs was not associated with COVID-19 severity (adjusted OR 1.074, 0.355-3.194).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Lymphocyte subsets were not significantly different between SARS-CoV-2 negative and positive patients and between mild versus severe cases. Neither lymphocyte subsets nor prior immunosuppressive drug use were associated with COVID-19 severity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2024.1436637","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:10:09Z","timestamp":1733184609000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploring lymphocyte subsets in COVID-19 patients: insights from a tertiary academic medical center with a high proportion of patients on immunosuppression"],"prefix":"10.3389","volume":"15","author":[{"given":"Katrijn","family":"Daenen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"van Hooijdonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirby","family":"Tong-Minh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem A.","family":"Dik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petrus M.","family":"van Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jilske A.","family":"Huijben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diederik","family":"Gommers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric C. M.","family":"van Gorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Endeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virgil A. S. H.","family":"Dalm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,3]]},"reference":[{"key":"B1","unstructured":"WHO Coronavirus (COVID-19) Dashboard"},{"key":"B2","doi-asserted-by":"publisher","first-page":"100461","DOI":"10.1016\/j.lana.2023.100461","article-title":"COVID-19 hospitalisations in immunocompromised individuals in the Omicron era: a population-based observational study using surveillance data in British Columbia, Canada","volume":"20","author":"Bahremand","year":"2023","journal-title":"Lancet Reg Health Am"},{"key":"B3","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.annonc.2021.02.024","article-title":"Painter CA et\u00a0al: Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium","volume":"32","author":"Grivas","year":"2021","journal-title":"Ann Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31187-9","article-title":"et al: Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study","volume":"395","author":"Kuderer","year":"2020","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-068632","article-title":"Chan YH et\u00a0al: Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis","volume":"376","author":"Lee","year":"2022","journal-title":"BMJ"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000000744","article-title":"Li CH et\u00a0al: Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province","volume":"133","author":"Liu","year":"2020","journal-title":"Chin Med J (Engl)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11081368","article-title":"Ceccarelli G et\u00a0al: Clinical Characteristics and Outcome of Patients with Suspected COVID-19 in Emergency Department (RESILIENCY Study II)","volume":"11","author":"Russo","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/v15081764","article-title":"Young J et\u00a0al: Characterizing Risk Factors for Hospitalization and Clinical Characteristics in a Cohort of COVID-19 Patients Enrolled in the GENCOV Study","volume":"15","author":"Morgan","year":"2023","journal-title":"Viruses"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1585","article-title":"Xiong Y et\u00a0al: Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"B10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cytogfr.2020.04.002","article-title":"Qiu Y et\u00a0al: Cytokine storm intervention in the early stages of COVID-19 pneumonia","volume":"53","author":"Sun","year":"2020","journal-title":"Cytokine Growth Factor Rev"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.accpm.2020.05.008","article-title":"Perrigault PF et\u00a0al: Prioritisation of ICU treatments for critically ill patients in a COVID-19 pandemic with scarce resources","volume":"39","author":"Leclerc","year":"2020","journal-title":"Anaesth Crit Care Pain Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.24172","article-title":"Lymphocyte subset counts in COVID-19 patients: A meta-analysis","volume":"97","author":"Huang","year":"2020","journal-title":"Cytometry A"},{"key":"B13","doi-asserted-by":"publisher","first-page":"118167","DOI":"10.1016\/j.lfs.2020.118167","article-title":"The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis","volume":"258","author":"Akbari","year":"2020","journal-title":"Life Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_2196_20","article-title":"Immuno-inflammatory predictors of disease severity in COVID-19: A systematic review and meta-analysis","volume":"10","author":"Panda","year":"2021","journal-title":"J Family Med Prim Care"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2020.12.003","article-title":"Increased age, neutrophil-to-lymphocyte ratio (NLR) and white blood cells count are associated with higher COVID-19 mortality","volume":"40","author":"Vafadar Moradi","year":"2021","journal-title":"Am J Emerg Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12879-020-05741-w","article-title":"Tan XW et\u00a0al: Clinical characteristics and predictive value of lower CD4(+)T cell level in patients with moderate and severe COVID-19: a multicenter retrospective study","volume":"21","author":"Wen","year":"2021","journal-title":"BMC Infect Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202305_32489","article-title":"Association of interleukin-6 and CD4+ T cells and two-week prognosis of patients with COVID-19: a predictive role","volume":"27","author":"Mu","year":"2023","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2022.5357","article-title":"Bilen MA et\u00a0al: Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19","volume":"9","author":"Bakouny","year":"2023","journal-title":"JAMA Oncol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.ccm.2022.11.012","article-title":"Coronavirus disease-2019 in the immunocompromised host","volume":"44","author":"Bertini","year":"2023","journal-title":"Clin Chest Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00827","article-title":"Wang G et\u00a0al: Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12879-021-05847-9","article-title":"Differences of blood cells, lymphocyte subsets and cytokines in COVID-19 patients with different clinical stages: a network meta-analysis","volume":"21","author":"Yan","year":"2021","journal-title":"BMC Infect Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2023.01.010","article-title":"Steroid-induced secondary immune deficiency","volume":"130","author":"Mustafa","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10040806","article-title":"A new early predictor of fatal outcome for COVID-19 in an italian emergency department: the modified quick-SOFA","volume":"10","author":"Guarino","year":"2022","journal-title":"Microorganisms"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.01.007","article-title":"Adaptive immunity to SARS-cov-2 and COVID-19","volume":"184","author":"Sette","year":"2021","journal-title":"Cell"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1172\/JCI140965","article-title":"SARS-CoV-2-specific T cell responses and correlations with COVID-19 patient predisposition","volume":"130","author":"Sattler","year":"2020","journal-title":"J Clin Invest"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1436637\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:10:13Z","timestamp":1733184613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1436637\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,3]]},"references-count":25,"alternative-id":["10.3389\/fimmu.2024.1436637"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1436637","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,3]]},"article-number":"1436637"}}